$48.68
-0.06-0.12%
最終更新: Oct 29, 7:36 PM
Benzinga
Benzinga
Benzinga
金曜日, 10 30
Benzinga
© 2026 Benzinga | All Rights Reserved
GSK (GSK) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
GSK (GSK) は、10 28, 2026日にfiscal yearの2031に関するガイダンスを直近で発表しました。同社は当期の売上高をの範囲と予想しています。
以前のガイダンスと比較して、GSKは売上高予測を以前の範囲である維持から$44.75B - $44.75Bに引き上げました。
GSKは、17から11 2, 2022の間に10 28, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 6 times and lowered it 5 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.40 | $1.27 | $1.17 | $0.64 |
| Actual | $1.47 | $1.35 | $1.25 | $0.68 |
| Surprise | +4.86% | +6.61% | +6.84% | +6.25% |
| Revenue | ||||
| Estimate | $11.80B | $10.79B | $10.19B | $11.19B |
| Actual | $11.95B | $11.28B | $10.30B | $11.46B |
| Surprise | +1.25% | +4.54% | +1.07% | +2.41% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.78 | $1.27 | $1.35 | $1.54 |
| Revenue | ||||
| Consensus | $12.09B | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q3 | Oct 28, 2026 | $1.47 | $1.40 | 4.86 % |
| Q2 | Jul 28, 2026 | $1.35 | $1.27 | 6.61 % |
| Q1 | Apr 29, 2026 | $1.25 | $1.17 | 6.84 % |
| Q4 | Feb 4, 2026 | $0.68 | $0.64 | 6.25 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q3 | Oct 28, 2026 | $11.95B | $11.80B | 1.25 % |
| Q2 | Jul 28, 2026 | $11.28B | $10.79B | 4.54 % |
| Q1 | Apr 29, 2026 | $10.30B | $10.19B | 1.07 % |
| Q4 | Feb 4, 2026 | $11.46B | $11.19B | 2.41 % |